|
|
Yale SPORE in Skin Cancer
|
5P50CA121974-02
|
$2,233,300
|
$558,325
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$8,260
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$4,200
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$8,794
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$14,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$17,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$182,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
$355,490
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
|
X-ray Targeted Therapeutic Genes within Nanoparticles
|
1R01CA125757-01A1
|
$364,320
|
$182,160
|
Hallahan, Dennis
|
VANDERBILT UNIVERSITY
|
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
$334,381
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$403,904
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$9,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$16,333
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy
|
1R01CA221197-01
|
$633,169
|
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-09
|
$645,635
|
$64,564
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
|
VITAMIN D PLANT ANTIOXIDANT SILIBININ IN LEUKEMIA TRANSLATIONAL STUDY
|
1R01CA117942-01A2
|
$203,600
|
$203,600
|
STUDZINSKI, GEORGE
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-03
|
$244,382
|
$36,657
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
|
Virtual Transportation as a Strategy to Reduce Resistance to Cigarette and e-Cigarette Graphic Health Warnings in Adolescents and Young Adults
|
7R01CA214587-02
|
$387,354
|
|
BLANTON, HART
|
TEXAS A&M UNIVERSITY
|
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$32,000
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$156,400
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Viral Vectors in Tumors: Effects of Taxol and Radiation
|
5R01CA098706-05
|
$268,835
|
$134,418
|
BOUCHER, YVES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Vindoline and Vinblastine
|
5R01CA115526-02
|
$320,404
|
$320,404
|
BOGER, DALE
|
SCRIPPS RESEARCH INSTITUTE
|
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-02
|
$176,231
|
$176,231
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
|
Vermont PROSPR Research Center (VPRC)
|
3U54CA163303-05S3
|
$608,939
|
|
SPRAGUE, BRIAN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-02S2
|
$25,857
|
$8,533
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VCU Minority-Based CCOP
|
3U10CA052784-17S1
|
$100,000
|
$45,000
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Minority-Based CCOP
|
5U10CA052784-17
|
$527,332
|
$237,299
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
$216,417
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S1
|
$124,341
|
$12,434
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S2
|
$19,990
|
$1,999
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
1R21CA119142-01A1
|
$164,365
|
$164,365
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
|
Vanderbilt Phase I Translational Research Program
|
5U01CA099177-05
|
$100,037
|
$100,037
|
ROTHENBERG, MACE
|
VANDERBILT UNIVERSITY
|
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
3U01CA200466-02S1
|
$129,694
|
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Validating Molecular Signature Risk Models of NSCLC
|
5R01CA116648-02
|
$535,358
|
$267,679
|
HARPOLE, DAVID
|
DUKE UNIVERSITY
|
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-34
|
$4,748,000
|
$664,720
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S1
|
$56,723
|
$7,941
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S2
|
$239,556
|
$33,538
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UTMDACC SPORE in Breast Cancer
|
3P50CA116199-03S1
|
$398,581
|
$79,716
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-03
|
$2,180,817
|
$436,163
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$272,441
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer
|
1R01CA123277-01A1
|
$311,283
|
$311,283
|
BEDI, ATUL
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Using Physiological Age to Predict Chemotherapy Toxicity
|
1R01CA124924-01
|
$611,423
|
$611,423
|
MANDELBLATT, JEANNE
|
GEORGETOWN UNIVERSITY
|
|
|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
5R42CA168107-04
|
$307,237
|
|
MCLAUGHLIN, JEFFERY
|
RADIANT CREATIVE GROUP, LLC
|
|
|
Use p105(sr) to study p50 homodimer in skin tumor/cancer
|
5R01CA104912-04
|
$203,349
|
$203,349
|
LIN, LI
|
MEDSTAR RESEARCH INSTITUTE
|
|
|
Use of Serum HPV16 DNA as a Marker for Oropharyngeal Cancer Recurrence
|
1R03CA128110-01A1
|
$77,000
|
$38,500
|
STURGIS, ERICH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Use of Claims Data to Study Quality of Cancer Care
|
5R01CA104949-04
|
$161,072
|
$80,536
|
GOODWIN, JAMES
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
|
Use of Beta-Lapachone for Lung Cancer Chemotherapy
|
3R01CA102792-04S1
|
$26,169
|
$26,169
|
Boothman, David
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
Total relevant funding to Chemotherapy for this search: $594,392,354
|
